Allogeneic haematopoietic cell transplantation with nonmyeloablative conditioning in Denmark.
BACKGROUND
Haematopoietic cell transplantation with nonmyeloablative conditioning (NMC-HCT) is used in the treatment of haematological malignancies.


METHODS
Use of NMC-HCT in Denmark from 2000-07 was examined.


RESULTS
Unrelated donor searches resulted in a suitable donor in 75% of cases of which 36% were transplanted. Among 244 patients referred for NMC-HCT, 72% were transplanted. There was a significant difference in the number of NMC-HCTs between national regions. Increasing waiting time resulted in 22% of the referred patients being taken off the waiting list without NMC-HCT.


CONCLUSIONS
Some patients may have had a chance of cure if they had been transplanted without delay.
Masmas
Tania Nicole
TN
Haematologisk Klinik, Rigshospitalet, 2100 København Ø, Denmark. masmas@dadlnet.dk
Kornblit
Brian
B
Sengeløv
Henrik
H
Madsen
Hans O
HO
Jakobsen
Bodil K
BK
Olesen
Gitte
G
Vindeløv
Lars L
LL
D019337:Hematologic Neoplasms / Q000401:mortality / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006648:Histocompatibility; D006801:Humans; D015996:Survival Rate; D019172:Transplantation Conditioning / Q000379:methods; D014184:Transplantation, Homologous; D014850:Waiting Lists